Posttranslational inactivation of human xanthine oxidoreductase by oxygen under standard cell culture conditions

American Journal of Physiology - Cell Physiology

Volumn 285, Issue 1 54-1, 2003, Pages

  Linder, Nina ^a   Martelin, Eeva ^a   Lapatto, Risto ^a   Raivio, Kari O ^a  

^a UNIVERSITY OF HELSINKI   (Finland)

Author keywords

Hyperoxia; Hypoxia; Ischemia reperfusion; Xanthine oxidase

Indexed keywords

FLAVINE ADENINE NUCLEOTIDE; HYDROGEN PEROXIDE; MESSENGER RNA; MOLYBDENUM; OXYGEN; REDUCED NICOTINAMIDE ADENINE DINUCLEOTIDE; XANTHINE OXIDASE;

ARTICLE; BRONCHUS MUCOSA; CATABOLISM; CELL CULTURE; CELL DAMAGE; CELL GROWTH; CELL HYPOXIA; CONTROLLED STUDY; ENZYME ACTIVITY; ENZYME INACTIVATION; ENZYME INDUCTION; ENZYME MECHANISM; ENZYME METABOLISM; GENE CONSTRUCT; GENETIC TRANSCRIPTION; HUMAN; HUMAN CELL; HYPEROXIA; NUCLEOTIDE SEQUENCE; OXIDATION; PRIORITY JOURNAL; PROMOTER REGION; PROTEIN DETERMINATION; PURINE METABOLISM; REDUCTION; REPERFUSION INJURY; RNA TRANSLATION;

BRONCHUS;

EID: 0038679357     PISSN: 03636143     EISSN: None     Source Type: Journal    
DOI: 10.1152/ajpcell.00561.2002     Document Type: Article

References (44)

1. Beinert H, Holm RH, and Munck E. Iron-sulfur clusters: nature's modular, multipurpose structures. Nature 277: 653-659, 1997.
2. Betcher-Lange SL, Coughlan MP, and Rajagopalan KV. Syncatalytic modification of chicken liver xanthine dehydrogenase by hydrogen peroxide. The nature of the reaction. J Biol Chem 254: 8825-8829, 1979.
3. Boveris A and Chance B. The mitochondrial generation of hydrogen peroxide. General properties and effect of hyperbaric oxygen. Biochem J 134: 707-716, 1973.
4. Bunn HF and Poyton RO. Oxygen sensing and molecular adaptation to hypoxia. Physiol Rev 76: 839-885, 1996.
5. Chomczynski P and Sacchi N. Single-step method of RNA isolation by acid guanidinium thiocyanate-phenol-chloroform extraction. Anal Biochem 162: 156-159, 1987.
6. Dang Y, Xia C, and Brown OR. Effects of oxygen on 3-hydroxyanthranilate oxidase of the kynurenine pathway. Free Radic Biol Med 25: 1033-1043, 1998.
7. Epstein FH, Agmon Y, and Brezis M. Physiology of renal hypoxia. Ann NY Acad Sci 718: 72-81; discussion 81-82, 1994.
8. Granger DN. Role of xanthine oxidase and granulocytes in ischemia-reperfusion injury. Am J Physiol Heart Circ Physiol 255: H1269-H1275, 1988.
9. Guillemin K and Krasnow MA. The hypoxic response: Huffing and HIFing. Cell 89: 9-12, 1997.
10. Hanson ES, Foot LM, and Leibold EA. Hypoxia post-translationally activates iron-regulatory protein 2. J Biol Chem 274: 5047-5052, 1999.
11. Hassoun PM, Yu FS, Shedd AL, Zulueta JJ, Thannickal VJ, Lanzillo JJ, and Fanburg BL. Regulation of endothelial cell xanthine dehydrogenase xanthine oxidase gene expression by oxygen tension. Am J Physiol Lung Cell Mol Physiol 266: L163-L171, 1994.
12. Hille R and Nishino T. Flavoprotein structure and mechanism. Xanthine oxidase and xanthine dehydrogenase. FASEB J 9: 995-1003, 1995.
13. Hoidal JR, Xu P, Huecksteadt T, Sanders KA, and Pfeffer K. Transcriptional regulation of human xanthine dehydrogenase/xanthine oxidase. Biochem Soc Trans 25: 796-799, 1997.
14. Ichida K, Matsumura T, Sakuma R, Hosoya T, and Nishino T. Mutation of human molybdenum cofactor sulfurase gene is responsible for classical xanthinuria type II. Biochem Biophys Res Commun 282: 1194-1200, 2001.
15. Ichimori K, Fukahori M, Nakazawa H, Okamoto K, and Nishino T. Inhibition of xanthine oxidase and xanthine dehydrogenase by nitric oxide. Nitric oxide converts reduced xanthine-oxidizing enzymes into the desulfo-type inactive form. J Biol Chem 274: 7763-7768, 1999.
16. Ikegami T and Nishino T. The presence of desulfo xanthine dehydrogenase in purified and crude enzyme preparations from rat liver. Arch Biochem Biophys 247: 254-260, 1986.
17. 2 sensing. Science 292: 464-468, 2001.
18. 2-regulated prolyl hydroxylation. Science 292: 468-472, 2001.
19. 2 tension. Am J Physiol Cell Physiol 271: C1172-C1180, 1996.
20. Kallio PJ, Okamoto K, O'Brien S, Carrero P, Makino Y, Tanaka H, and Poellinger L. Signal transduction in hypoxic cells: inducible nuclear translocation and recruitment of the CBP/p300 coactivator by the hypoxia-inducible factor-1α. EMBO J 17: 6573-6586, 1998.
21. Kayyali US, Donaldson C, Huang H, Abdelnour R, and Hassoun PM. Phosphorylation of xanthine dehydrogenase/oxidase in hypoxia. J Biol Chem 276: 14359-14365, 2001.
22. Martelin E, Lapatto R, and Raivio KO. Regulation of xanthine oxidoreductase by intracellular iron. Am J Physiol Cell Physiol 283: C1722-C1728, 2002.
23. Martelin E, Palvimo JJ, Lapatto R, and Raivio KO. Nuclear factor Y activates the human xanthine oxidoreductase gene promoter. FEBS Lett 480: 84-88, 2000.
24. McCord JM. Oxygen-derived free radicals in postischemic tissue injury. N Engl J Med 312: 159-163, 1985.
25. Nishino T, Usami C, and Tsushima K. Reversible interconversion between sulfo and desulfo xanthine oxidase in a system containing rhodanese, thiosulfate, and sulfhydryl reagent. Proc Natl Acad Sci USA 80: 1826-1829, 1983.
26. Packer L and Fuehr K. Low oxygen concentration extends the lifespan of cultured human diploid cells. Nature 267: 423-425, 1977.
27. Parks DA and Granger DN. Xanthine oxidase: biochemistry, distribution and physiology. Acta Physiol Scand Suppl 548: 87-99, 1986.
28. Poss WB, Huecksteadt TP, Panus PC, Freeman BA, and Hoidal JR. Regulation of xanthine dehydrogenase and xanthine oxidase activity by hypoxia. Am J Physiol Lung Cell Mol Physiol 270: L941-L946, 1996.
29. Ratcliffe PJ, O'Rourke JF, Maxwell PH, and Pugh CW. Oxygen sensing, hypoxia-inducible factor-1 and the regulation of mammalian gene expression. J Exp Biol 201: 1153-1162, 1998.
30. Rumsey WL, Pawlowski M, Lejavardi N, and Wilson DF. Oxygen pressure distribution in the heart in vivo and evaluation of the ischemic "border zone." Am J Physiol Heart Circ Physiol 266: H1676-H1680, 1994.
31. Saksela M, Lapatto R, and Raivio KO. Xanthine oxidoreductase gene expression and enzyme activity in developing human tissues. Biol Neonate 74: 274-280, 1998.
32. Saksela M and Raivio KO. Cloning and expression in vitro of human xanthine dehydrogenase/oxidase. Biochem J 315: 235-239, 1996.
33. Sarnesto A, Linder N, and Raivio KO. Organ distribution and molecular forms of human xanthine dehydrogenase/xanthine oxidase protein. Lab Invest 74: 48-56, 1996.
34. Saugstad OD. Hypoxanthine as an indicator of hypoxia: its role in health and disease through free radical production. Pediatr Res 23: 143-150, 1988.
35. Semenza GL. Perspectives on oxygen sensing. Cell 98: 281-284, 1999.
36. Stirpe F and Della Corte E. The regulation of rat liver xanthine oxidase conversion in vitro of the enzyme activity from dehydrogenase (type D) to oxidase (type 0). J Biol Chem 244: 3855-3863, 1969.
37. 2 metabolites inactivate xanthine oxidase. J Appl Physiol 65: 2349-2353, 1988.
38. Terada LS, Guidot DM, Leff JA, Willingham IR, Hanley ME, Piermattei D, and Repine JE. Hypoxia injures endothelial cells by increasing endogenous xanthine oxidase activity. Proc Natl Acad Sci USA 89: 3362-3366, 1992.
39. Terada LS, Piermattei D, Shibao GN, McManaman JL, and Wright RM. Hypoxia regulates xanthine dehydrogenase activity at pre- and posttranslational levels. Arch Biochem Biophys 348: 163-168, 1997.
40. 2-dependent (type O) forms of rat liver xanthine dehydrogenase. Arch Biochem Biophys 172: 354-364, 1976.
41. 2 of cat cerebral cortex. Stroke 1: 194-200, 1970.
42. Wiezorek JS, Brown DH, Kupperman DE, and Brass CA. Rapid conversion to high xanthine oxidase activity in viable Kupffer cells during hypoxia. J Clin Invest 94: 2224-2230, 1994.
43. Wolfle D, Schmidt H, and Jungermann K. Short-term modulation of glycogen metabolism, glycolysis and gluconeogenesis by physiological oxygen concentrations in hepatocyte cultures. Eur J Biochem 135: 405-412, 1983.
44. Xu P, Huecksteadt TP, and Hoidal JR. Molecular cloning and characterization of the human xanthine dehydrogenase gene (XDH). Genomics 34: 173-180, 1996.